Skip to content

InnovAge Holdings, Inc. INNV Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Humana logo
HumanaHUM
$990M-33.2%
Astrana Health logo
Astrana HealthASTH
$0-100%
Centene logo
CenteneCNC
$0-100%
PACS Group logo
PACS GroupPACS
$45M

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+150%
Enterprise value$1.31B+130%
P/S1.4×+0.7×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s debt issuance proceeds?
InnovAge Holdings, Inc. (INNV) reported debt issuance proceeds of $60.08M in Q3 2025.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.